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Introduction

Results

Approximately 17.8% of the US GDP in 2015 was spent on
healthcare.1 Notably, 5% of the patient population accounts
for 50% of that healthcare spending.2 There have been many
initiatives set forth for reducing healthcare cost within many
healthcare systems. Most healthcare groups focus on targeting
the “hot-spotters” who are super utilizers;3 however, the
population that cannot be taken for granted are high-risk patients,
defined as those who can be predicted to over-utilize in the
future. Utilization in healthcare was defined as consumption of
services or supplies, such as office visits, number of prescription
drugs taken, or number of days hospitalized.4 Within that subset
of utilizers, about 6.4% of Americans, 15.7 million, have been
diagnosed with COPD.5 COPD was the fifth leading cause of death
in the United States in 2015.6 Previous studies have shown the
link between depression and COPD, suggesting that individuals
with chronic conditions, such as COPD, are more likely to have
depression. They have also shown that depressive symptoms
– including lack of sleep or fluctuating eating habits – have
contributed to worsening dyspnea, increased COPD exacerbations,
more frequent ED visits, and hospitalizations. This analysis aims
to look at the effect depression has on the care and cost of Lehigh
Valley Health Network’s (LVHN) COPD population. As part of a
secondary analysis, it will also look at the effect of insurance
status (e.g., commercial or Medicare on the two cohorts (e.g.,
COPD patients with depression and COPD patients without
depression).

•	This analysis suggested a positive correlation between depression and increased ambulatory
visits, emergency visits, hospitalizations, and 30-day readmissions in COPD patients, regardless of
insurance provider.
•	This was reflected in increased costs for COPD patients with depression compared to those without.
•	Medicare beneficiaries had increased utilization and cost compared to the commercially insured.
•	This analysis also demonstrated a difference between the risk adjustment factor (RAF) between
the COPD cohort without depression (average RAF of 1.012) and the COPD cohort with depression
(average RAF of 1.552), signifying about a 53% increase. As the COPD severity worsened, the RAF
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score increased.
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Figure 2: Average Number of COPD-related Visits. This figure
demonstrates that in the MSSP population, the ambulatory visits,
emergency visits, and hospitalizations, and 30-day readmissions were
43%, 115%, 104%, and 143% greater in patients with depression than
without, respectively. In the commercially insured, the rates of emergency
visits, hospitalizations, and 30-day readmissions were 22%, 4%, and
50% greater in patients with depression than without, respectively.
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Figure 3: Average Cost for all COPD-Related Visits. In the MSSP
population, cost for ambulatory visits, ED visits, and hospitalizations were
36%, 160%, and110% increased in patients with depression compared to
those without, respectively. Likewise, in the commercial population, cost
for ambulatory visits, ED visits, and hospitalizations were 105%, 213%,
and 133% increased in patients with depression compared to those
without, respectively.
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Methods
•	A retrospective quality improvement analysis of two cohorts:
LVHN’s COPD population with depression (n= 12,802) and
LVHN’s COPD population without depression (n = 26,868), ages
ranging from 21-106 for whom three years of data was collected
(01/01/2014 -11/30/2017).
•	The two cohorts were further compared by insurance providers
(i.e., commercial and Medicare).
•	The data was collected through healthcare intelligence software
(e.g., Optum One) that pulled from electronic medical records and
claims
•	Gained buy-in at meetings with the Senior Medical Director of
Population Health and Payer Relations, the Executive Director of
LVPHO, and pulmonology care management leaders
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Figure 4: Driver Diagram for reduction of depression within the COPD cohort. The above diagram shows factors that interplay
with why COPD patients with depression have increased utlization and cost, along with ideas on how to reduce these rates.

Conclusions and Future Work
There is a positive correlation between depression and increased health care utilization for patients with COPD,
regardless of health insurance provider. Furthermore, Medicare beneficiaries with COPD and depression are at an
even higher risk for increased utilization. In the future, further investigation of potential countermeasures, such as
earlier diagnosis (e.g., increased PHQ-9 screening), improved treatment of depression, and adoption of innovative
techniques (e.g., telemedicine) should be done to elaborate on ways of decreasing utilization and optimizing quality
outcomes for the cohort of patients with COPD and depression.
This project mainly encompasses all three pillars of SELECT. In regards to healthcare, we strived to improve
utilization outcomes by targeting high-risk COPD patients and looking at the relationship between those who have
depression compared to those without. As the trend detected showed increased ED visits, hospitalizations and 30day readmission rates in those with depression, the next discussion lies in whether these patients are satisfied with
their quality of care and whether their care aligns with their values. Lastly, I personally grew as a leader through
my communication skills, in my ability to influence others with data, in my ability to manipulate data on multiple
software programs, and learn from others who have mastered topics I have not.
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Figure 1: Closer look: COPD populations analyzed
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